Send me a link:

*Text messaging rates may apply.

 Dow Up0.10% Nasdaq Down0.03%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
36.53 Down 1.15(3.05%) 2:33PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 13,625   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit 13,625   -   -   -  
Operating Expenses
Research Development24,151  22,544  16,063  15,816  
Selling General and Administrative6,142  5,950  4,312  3,492  
Non Recurring8,406   -   -   -  
Others3,409   -   -   -  
Total Operating Expenses42,108   -   -   -  
Operating Income or Loss (28,483) (28,494) (20,375) (19,308)
Income from Continuing Operations
Total Other Income/Expenses Net(106)(657)55  (33)
Earnings Before Interest And Taxes(28,589)(29,151)(20,320)(19,341)
Interest Expense -   -   -   -  
Income Before Tax(28,589)(29,151)(20,320)(19,341)
Income Tax Expense2,129  52   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(30,718)(29,203)(20,320)(19,341)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (30,718) (29,203) (20,320) (19,341)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (30,718) (29,203) (20,320) (19,341)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.